Truist Financial Corp Myriad Genetics Inc Transaction History

Truist Financial Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 18, 2021	SELL	$12.16 - $19.77 $204,190 - $331,977	-16,792 Reduced 56.24%	13,067 $260,000
Q3 2020 Nov 13, 2020	SELL	$11.25 - $14.75 $25,582 - $33,541	-2,274 Reduced 7.08%	29,859 $389,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $25,966 - $40,054	-2,429 Reduced 7.03%	32,133 $365,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $25,232 - $76,187	-2,580 Reduced 6.95%	34,562 $494,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $53,559 - $89,820	2,559 Added 7.4%	37,142 $1.01 Million
Q3 2019 Oct 31, 2019	SELL	$22.08 - $47.08 $70,081 - $149,431	-3,174 Reduced 8.41%	34,583 $990,000
Q2 2019 Jul 24, 2019	SELL	$22.67 - $35.0 $198,317 - $306,180	-8,748 Reduced 18.81%	37,757 $1.05 Million
Q1 2019 Apr 23, 2019	SELL	$26.93 - $34.7 $100,421 - $129,396	-3,729 Reduced 7.42%	46,505 $1.54 Million
Q4 2018 Jan 22, 2019	SELL	$27.23 - $45.56 $202,536 - $338,875	-7,438 Reduced 12.9%	50,234 $1.46 Million
Q3 2018 Oct 17, 2018	SELL	$37.57 - $50.34 $486,719 - $652,154	-12,955 Reduced 18.34%	57,672 $2.65 Million
Q2 2018 Jul 26, 2018	SELL	$27.75 - $40.17 $576,339 - $834,290	-20,769 Reduced 22.72%	70,627 $2.64 Million
Q1 2018 Apr 20, 2018	SELL	$28.83 - $41.01 $776,709 - $1.1 Million	-26,941 Reduced 22.77%	91,396 $2.7 Million
Q4 2017 Jan 29, 2018	SELL	$28.45 - $37.14 $904,937 - $1.18 Million	-31,808 Reduced 21.18%	118,337 $4.06 Million
Q3 2017 Oct 23, 2017	BUY	$24.01 - $36.2 $3.6 Million - $5.44 Million	150,145	150,145 $5.43 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.